Target Healthcare Group Holdings Limited joins Bio Tech Pharma Limited
Published
Bio Tech Pharma Limited is a Newcastle Upon Tyne based company that provides information services and patent and copyright agency activities. Founded in 2014, the firm also undertakes legal activities. The latest confirmation statement, covering the period up to 7 July 2026, reveals a shift in the company ownership structure.
Target Healthcare Group Holdings Limited has joined the cap table as a new shareholder, holding 200 Ordinary shares. This entry follows the exit of Target Healthcare Group Limited, which previously held the same 200 Ordinary shares. The change indicates a full transfer of the 200 shares from the departing entity to the new entrant.
Existing records show that Pharmadent Limited remains on the cap table, although it currently holds 0 shares. The filing, which was processed at Companies House on 13 July 2026, confirms that the 200 Ordinary shares now held by Target Healthcare Group Holdings Limited constitute the active shareholding reported in this period. Bio Tech Pharma Limited has maintained its operations in the North East for twelve years. This shareholder change reflects a reorganization of the primary stakeholder position within the company.
Shareholder data
Source: Companies House confirmation statement (CS01) — period to , filed .
Changes in this confirmation statement
| Type | Shareholder | Shares | Change | Share classes |
|---|---|---|---|---|
| Exited | TARGET HEALTHCARE GROUP LIMITED | 200 | — | ORDINARY 200 |
| New shareholder | TARGET HEALTHCARE GROUP HOLDINGS LIMITED | 200 | — | ORDINARY 200 |
Current shareholders (1)
| Shareholder | Total shares | Share classes |
|---|---|---|
| TARGET HEALTHCARE GROUP HOLDINGS LIMITED | 200 | ORDINARY 200 |
Contact the editorial team at [email protected]